Enhanced tumor control with a combination of APG-157 and immune checkpoint inhibitors for head and neck cancer.

APG-157 - Aveta Biomics

Daniel Sanghoon Shin; Saroj K. Basak; Mysore S. Veena; Begoña Comin-Anduix; Arjun Bhattachrya; Tien Dong; Luis Z. Avila; Marilene Wang; Eri Srivatsan

Apr 28, 2022